Published in Lancet Neurol on April 01, 2008
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol (2010) 4.37
Psychosocial distress and stroke risk in older adults. Stroke (2012) 3.83
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol (2009) 2.98
Post-stroke infection: a systematic review and meta-analysis. BMC Neurol (2011) 2.29
Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis (2014) 1.91
Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab (2010) 1.85
Infection, vaccination, and childhood arterial ischemic stroke: Results of the VIPS study. Neurology (2015) 1.71
HIV infection and stroke: current perspectives and future directions. Lancet Neurol (2012) 1.66
HIV, antiretroviral treatment, hypertension, and stroke in Malawian adults: A case-control study. Neurology (2015) 1.62
Activation of α-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress. PLoS One (2014) 1.52
Chickenpox and risk of stroke: a self-controlled case series analysis. Clin Infect Dis (2013) 1.51
Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J Neurosci (2010) 1.40
Bone Fracture Pre-Ischemic Stroke Exacerbates Ischemic Cerebral Injury in Mice. PLoS One (2016) 1.38
Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size. J Neuroinflammation (2011) 1.32
Does inflammation after stroke affect the developing brain differently than adult brain? Dev Neurosci (2009) 1.30
An early rise in body temperature is related to unfavorable outcome after stroke: data from the PAIS study. J Neurol (2010) 1.25
IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab Brain Dis (2013) 1.11
Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One (2010) 1.10
Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses. J Cereb Blood Flow Metab (2010) 1.08
Depressive symptoms predict incident stroke independently of memory impairments. Neurology (2010) 1.07
Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis (2013) 1.06
C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol (2009) 1.05
Role of spleen-derived monocytes/macrophages in acute ischemic brain injury. J Cereb Blood Flow Metab (2014) 1.04
Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp Neurol (2013) 1.03
The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev (2015) 0.99
Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res (2013) 0.97
Infection after intracerebral hemorrhage: risk factors and association with outcomes in the ethnic/racial variations of intracerebral hemorrhage study. Stroke (2014) 0.95
Interleukin-1 and acute brain injury. Front Cell Neurosci (2015) 0.95
Bone fracture exacerbates murine ischemic cerebral injury. Anesthesiology (2013) 0.94
Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection. J Neuroinflammation (2012) 0.93
Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: immunomodulation and neuroprotection by progesterone. Neuroscience (2012) 0.91
Prolonged, 24-h delayed peripheral inflammation increases short- and long-term functional impairment and histopathological damage after focal ischemia in the rat. J Cereb Blood Flow Metab (2010) 0.90
Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke. Biomed Res Int (2014) 0.87
Antigen-specific immune reactions to ischemic stroke. Front Cell Neurosci (2014) 0.86
A simple prediction score for developing a hospital-acquired infection after acute ischemic stroke. J Stroke Cerebrovasc Dis (2015) 0.86
Respiratory infections in acute stroke: nasogastric tubes and immobility are stronger predictors than dysphagia. Dysphagia (2014) 0.85
Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: a bed to bench approach. J Cereb Blood Flow Metab (2013) 0.84
Risk assessment of ischemic stroke associated pneumonia. World J Emerg Med (2014) 0.84
ROCKs as immunomodulators of stroke. Expert Opin Ther Targets (2012) 0.84
The effects of ceftriaxone on skill learning and motor functional outcome after ischemic cortical damage in rats. Restor Neurol Neurosci (2013) 0.84
Increased risk of stroke after septicaemia: a population-based longitudinal study in Taiwan. PLoS One (2014) 0.83
Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective. J Aging Res (2011) 0.83
2014 Thomas Willis Award Lecture: sex, stroke, and innovation. Stroke (2014) 0.83
Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases. PLoS One (2013) 0.82
Viral encephalitis and atherothrombotic stroke. BMJ Case Rep (2012) 0.82
External validation of the A2DS2 score to predict stroke-associated pneumonia in a Chinese population: a prospective cohort study. PLoS One (2014) 0.82
COPD and stroke: are systemic inflammation and oxidative stress the missing links? Clin Sci (Lond) (2016) 0.82
Role of the sympathetic nervous system and spleen in experimental stroke-induced immunodepression. Med Sci Monit (2014) 0.82
Majority of 30-Day Readmissions After Intracerebral Hemorrhage Are Related to Infections. Stroke (2016) 0.82
Effect of dexmedetomidine on early postoperative cognitive dysfunction and peri-operative inflammation in elderly patients undergoing laparoscopic cholecystectomy. Exp Ther Med (2015) 0.81
Simvastatin Reduces Lipopolysaccharides-Accelerated Cerebral Ischemic Injury via Inhibition of Nuclear Factor-kappa B Activity. Biomol Ther (Seoul) (2015) 0.80
Isoflurane preconditioning provides neuroprotection against stroke by regulating the expression of the TLR4 signalling pathway to alleviate microglial activation. Sci Rep (2015) 0.80
Cross-talk between the inflammatory response, sympathetic activation and pulmonary infection in the ischemic stroke. J Neuroinflammation (2014) 0.80
Imaging Evidence for Cerebral Hyperperfusion Syndrome after Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke. Case Rep Neurol Med (2016) 0.79
Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Res (2015) 0.79
Hypoxia after stroke: a review of experimental and clinical evidence. Exp Transl Stroke Med (2016) 0.79
Thiamet G mediates neuroprotection in experimental stroke by modulating microglia/macrophage polarization and inhibiting NF-κB p65 signaling. J Cereb Blood Flow Metab (2016) 0.79
Searching for prognostic variables for secondary worsening after ischaemic stroke. J Neurol (2010) 0.78
Correlation between inflammatory factors and post-stroke pneumonia in diabetic patients. Exp Ther Med (2013) 0.78
Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury. Sci Rep (2016) 0.78
Post-stroke bacteriuria among stroke patients attending a physiotherapy clinic in Ghana: a cross-sectional study. Ther Clin Risk Manag (2016) 0.77
Risk of Stroke-Associated Pneumonia With Acid-Suppressive Drugs: A Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.77
Study protocol: prediction of stroke associated infections by markers of autonomic control. BMC Neurol (2014) 0.76
Antigen Presentation After Stroke. Neurotherapeutics (2016) 0.76
Role of trauma and infection in childhood hemorrhagic stroke due to vascular lesions. Neurology (2013) 0.75
Stroke in Malawi--what do we know about it and how should we manage it? Manage it? Malawi Med J (2010) 0.75
Lipocalin-2 as an Infection-Related Biomarker to Predict Clinical Outcome in Ischemic Stroke. PLoS One (2016) 0.75
Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat Strain. Front Nutr (2016) 0.75
The neglected. Ann Med Health Sci Res (2013) 0.75
Predictors of early infection in cerebral ischemic stroke. J Med Life (2016) 0.75
Potential specific immunological indicators for stroke associated infection are partly modulated by sympathetic pathway activation. Oncotarget (2016) 0.75
Is early clinical evidence of autonomic shift predictive of infection after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis (2013) 0.75
Ischemic stroke induces gut permeability and enhances bacterial translocation leading to sepsis in aged mice. Aging (Albany NY) (2016) 0.75
Risk of Acute Stroke After Hospitalization for Sepsis: A Case-Crossover Study. Stroke (2017) 0.75
The Efficacy of Prophylactic Antibiotics on Post-Stroke Infections: An Updated Systematic Review and Meta-Analysis. Sci Rep (2016) 0.75
Herpes zoster and the risk of ischemic and hemorrhagic stroke: A systematic review and meta-analysis. PLoS One (2017) 0.75
Sustained inflammation 1.5 years post-stroke is not associated with depression in elderly stroke survivors. Clin Interv Aging (2013) 0.75
Association of HIV and Opportunistic Infections with Incident Stroke: A Nationwide Population-based Cohort Study in Taiwan. J Acquir Immune Defic Syndr (2016) 0.75
Prophylactic Antibiotic Therapy for Preventing Poststroke Infection. Neurotherapeutics (2016) 0.75
Childhood infections and trauma as risk factors for stroke. Curr Cardiol Rep (2014) 0.75
Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway. Acta Pharmacol Sin (2017) 0.75
Validation of risk scoring models for predicting stroke-associated pneumonia in patients with ischaemic stroke. Stroke Vasc Neurol (2016) 0.75
The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke. Front Neurol (2017) 0.75
Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort. Ann Rheum Dis (2017) 0.75
Preclinical Development of a Prophylactic Neuroprotective Therapy for the Preventive Treatment of Anticipated Ischemia-Reperfusion Injury. Transl Stroke Res (2017) 0.75
Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol (2004) 2.30
An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol (2003) 1.97
Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun (2011) 1.44
Different photoperiods affect proliferation of lymphocytes but not expression of cellular, humoral, or innate immunity in hamsters. J Biol Rhythms (2002) 1.40
Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J Neurotrauma (2007) 1.36
Interleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrations. J Cereb Blood Flow Metab (2007) 1.34
Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am J Physiol Endocrinol Metab (2002) 1.14
Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage. Br J Clin Pharmacol (2007) 1.12
Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study. J Cereb Blood Flow Metab (2010) 1.08
Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit Care (2008) 1.04
Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol (2007) 1.02
Variability of the systemic acute phase response after ischemic stroke. J Neurol Sci (2006) 0.95
Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice. Endocrinology (2003) 0.90
C-reactive protein predicts hematoma growth in intracerebral hemorrhage. Stroke (2013) 0.89
Post-stroke immunodepression and infection: an emerging concept. Infect Disord Drug Targets (2010) 0.88
C-reactive protein in intracerebral hemorrhage: time course, tissue localization, and prognosis. Neurology (2012) 0.88
Interleukin-1 receptor antagonist reverses stroke-associated peripheral immune suppression. Cytokine (2012) 0.88
Does inflammation predispose to recurrent vascular events after recent transient ischaemic attack and minor stroke? The North West of England transient ischaemic attack and minor stroke (NORTHSTAR) study. Int J Stroke (2011) 0.86
Correlation of systemic inflammatory response with infarct volume in acute ischemic stroke patients. Stroke (2004) 0.85
Infection and brain-induced immunodepression after acute ischemic stroke. Stroke (2007) 0.82
Variability of bacterial translocation in the absence of intestinal mucosal damage following injury and the influence of interleukin-6. Pathophysiology (2005) 0.79
Overcoming matrix matching problems in multiplex cytokine assays. J Immunol Methods (2013) 0.79
Simple, quantitative measurement of cytokine gene expression using an immunometric reverse transcriptase-polymerase chain reaction. J Immunol Methods (2003) 0.78
Academic medicine: time for reinvention: non-clinician scientists are the missing clinical links. BMJ (2004) 0.75
Reconstituting National Institute for Biological Standards and Control (NIBSC) chemokines. Cytokine (2012) 0.75
Comparison of 'real-time' and immunometric RT-PCR: RNA interference of reverse transcriptase-PCR. J Immunol Methods (2006) 0.75